Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)
CUSIP: 78667J108
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
- Shares outstanding
- 62,650,155
- Total 13F shares
- 49,060,569
- Share change
- -1,493,679
- Total reported value
- $2,173,846,483
- Put/Call ratio
- 220%
- Price per share
- $44.31
- Number of holders
- 215
- Value change
- -$115,480,957
- Number of buys
- 115
- Number of sells
- 121
Quarterly Holders Quick Answers
What is CUSIP 78667J108?
CUSIP 78667J108 identifies SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 78667J108:
Top shareholders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
11%
|
6,861,659
|
$389,810,000 | — | 30 Jun 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
9.3%
|
5,811,940
|
$330,177,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.7%
|
4,824,810
|
$274,097,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.5%
|
2,850,498
|
$161,938,000 | — | 30 Jun 2021 | |
| Bellevue Group AG |
13F
|
Company |
3.8%
|
2,364,204
|
$134,310,000 | — | 30 Jun 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2.7%
|
1,660,453
|
$94,330,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.5%
|
1,571,553
|
$89,280,000 | — | 30 Jun 2021 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
2.4%
|
1,521,580
|
$86,441,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,336,758
|
$75,941,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.1%
|
1,317,143
|
$74,827,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.8%
|
1,141,726
|
$64,862,000 | — | 30 Jun 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
1,094,000
|
$62,150,000 | — | 30 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
1.6%
|
1,000,000
|
$56,810,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
773,684
|
$43,952,000 | — | 30 Jun 2021 | |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP |
13F
|
Company |
1.2%
|
763,998
|
$43,349,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1%
|
645,810
|
$36,689,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.97%
|
606,910
|
$34,480,000 | — | 30 Jun 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.97%
|
604,941
|
$34,355,000 | — | 30 Jun 2021 | |
| Palo Alto Investors LP |
13F
|
Company |
0.96%
|
600,500
|
$34,114,000 | — | 30 Jun 2021 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.93%
|
582,120
|
$33,070,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.92%
|
577,716
|
$32,820,000 | — | 30 Jun 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.89%
|
556,204
|
$31,598,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.81%
|
507,506
|
$28,831,000 | — | 30 Jun 2021 | |
| NORGES BANK |
13F
|
Company |
0.75%
|
472,877
|
$26,864,000 | — | 30 Jun 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.66%
|
410,753
|
$23,335,000 | — | 30 Jun 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.59%
|
372,311
|
$21,150,000 | — | 30 Jun 2021 | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. |
13F
|
Company |
0.51%
|
321,613
|
$18,270,835 | — | 30 Jun 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.47%
|
291,989
|
$16,588,000 | — | 30 Jun 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.46%
|
289,570
|
$16,450,000 | — | 30 Jun 2021 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.46%
|
285,787
|
$16,236,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.44%
|
274,653
|
$15,602,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.44%
|
274,601
|
$15,600,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.44%
|
273,355
|
$15,530,000 | — | 30 Jun 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.43%
|
272,334
|
$15,471,000 | — | 30 Jun 2021 | |
| MERITAGE PORTFOLIO MANAGEMENT |
13F
|
Company |
0.43%
|
272,192
|
$15,463,000 | — | 30 Jun 2021 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.4%
|
250,000
|
$14,203,000 | — | 30 Jun 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.36%
|
228,200
|
$12,964,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.36%
|
227,799
|
$12,941,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.36%
|
226,444
|
$12,865,000 | — | 30 Jun 2021 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.36%
|
224,000
|
$12,725,000 | — | 30 Jun 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.32%
|
202,143
|
$11,483,000 | — | 30 Jun 2021 | |
| Amundi |
13F
|
Individual |
0.32%
|
200,261
|
$11,377,000 | — | 30 Jun 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.29%
|
179,119
|
$10,176,000 | — | 30 Jun 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.27%
|
170,306
|
$9,675,000 | — | 30 Jun 2021 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.27%
|
166,171
|
$9,440,000 | — | 30 Jun 2021 | |
| Aristotle Atlantic Partners, LLC |
13F
|
Company |
0.26%
|
161,205
|
$9,158,000 | — | 30 Jun 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.25%
|
157,738
|
$8,961,096 | — | 30 Jun 2021 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.25%
|
154,835
|
$8,796,000 | — | 30 Jun 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
146,546
|
$8,325,000 | — | 30 Jun 2021 | |
| Caption Management, LLC |
13F
|
Company |
0.22%
|
139,600
|
$7,931,000 | — | 30 Jun 2021 |
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q3 2021
As of 30 Sep 2021,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,060,569 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, VANGUARD GROUP INC, Bellevue Group AG, BlackRock Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, D. E. Shaw & Co., Inc., JPMORGAN CHASE & CO, and BOXER CAPITAL, LLC.
This page lists
216
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
246
Q3 2021 holders
215
Holder diff
-31
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.